Researchers are exploring considerations for selecting patients to receive gene therapy for AADC deficiency, a rare condition. Gene therapy has shown promise in delivering dopamine directly to the brain, but challenges remain in identifying suitable candidates. The development of gene therapies for neurologic disorders, including AADC deficiency, is an area of ongoing research and advancement.